Gluskin Sheff & Assoc Inc Pfizer Inc Transaction History

Gluskin Sheff & Assoc Inc

$832 Million
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $1.48 Million - $1.92 Million	-56,558 Reduced 62.98%	33,241 $957,000
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $442,842 - $517,638	-13,800 Reduced 13.32%	89,799 $2.98 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $586,047 - $678,042	-16,225 Reduced 13.54%	103,599 $3.8 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $2.72 Million - $3.55 Million	-69,155 Reduced 36.59%	119,824 $4.89 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $112,516 - $146,877	2,695 Added 1.45%	188,979 $9.69 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $78,155 - $95,408	-1,786 Reduced 0.95%	186,284 $8.15 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $602,051 - $713,844	12,939 Added 7.39%	188,070 $9.86 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $1.2 Million - $1.48 Million	26,163 Added 17.56%	175,131 $9.07 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $322,833 - $478,546	7,813 Added 5.54%	148,968 $8.8 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $7,653 - $9,831	195 Added 0.14%	141,155 $6.07 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $15,154 - $17,166	422 Added 0.3%	140,960 $5.52 Million
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $2.53 Million - $2.86 Million	-75,602 Reduced 34.98%	140,538 $5.09 Million
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $87,791 - $111,634	-2,623 Reduced 1.2%	216,140 $7.96 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $510,508 - $598,942	-16,079 Reduced 6.85%	218,763 $8.03 Million
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $4.63 Million - $5.62 Million	-153,676 Reduced 39.55%	234,842 $7.68 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $3.7 Million - $5.29 Million	136,919 Added 54.42%	388,518 $12.7 Million
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $1,580 - $1,793	-48 Reduced 0.02%	251,599 $9.66 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $7.99 Million - $10.4 Million	245,931 Added 4302.5%	251,647 $9.04 Million
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $29.2 Million - $32.1 Million	-779,999 Reduced 99.27%	5,716 $243,000
Q4 2018 Feb 12, 2019	SELL	$38.47 - $43.86 $437,519 - $498,819	-11,373 Reduced 1.43%	785,715 $34.3 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $4.57 Million - $5.54 Million	-132,615 Reduced 14.26%	797,088 $35.1 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $2.88 Million - $3.07 Million	-87,238 Reduced 8.58%	929,703 $33.7 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $10.2 Million - $11.8 Million	319,600 Added 45.83%	1,016,941 $36.1 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $320,160 - $339,701	-9,626 Reduced 1.36%	697,341 $25.3 Million
Q3 2017 Nov 01, 2017	BUY	$31.0 - $34.15 $21.9 Million - $24.1 Million	706,967	706,967 $25.2 Million

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$15.2 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$12.6 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$8.54 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.95 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.49 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gluskin Sheff & Assoc Inc, based on Form 13F filings with the SEC.

News

Stay updated on Gluskin Sheff & Assoc Inc with notifications on news.

Account